Pulmonary Hypertension

Questions discussed in this category

Would you perform screening for pulmonary hypertension in a patient who has biopsy-proven Sjogren's but has a centromere antibody?

If symptoms include only sicca and Raynaud's with no respiratory symptoms, would you still be concerned enough with the centromere antibody to screen ...

2 Answers available

How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?

No evidence of VTE on multiple scans. On Crizanlizumab but not tolerant of hydroxyurea. The patient is admitted frequently for VOCs with acute on chro...

1 Answer available

Have you noticed poor response to Tyvaso DPI compared to the nebulized form in PH-ILD?

Could the intrinsic inspiratory capacity and distribution of medication be different between the two routes?

1 Answer available

What protective post-op measures do you recommend for a patient with scleroderma and a history of ILD, PH, Raynaud’s and digital ischemia undergoing cardiothoracic surgery?

1 Answer available

How do you approach management of a patient with idiopathic PAH and +ANA, but no other current symptoms/signs of active rheumatologic disease?

3 Answers available

Do you prefer using end-expiratory or mean pulmonary artery wedge pressure obtained during diagnostic right heart catheterization for the classification of precapillary vs postcapillary PH?

1 Answer available

What strategies do you employ to minimize the risk of cardiovascular collapse when intubating a patient with severe pulmonary hypertension?

Do you favor awake intubation in these cases?

2 Answers available

When do you consider Balloon Pulmonary Angioplasty in patients with inoperable CTEPH?

1 Answer available

Is there a role for immunosuppression in addition to standard PAH therapy in the management of pulmonary hypertension associated with primary Sjogrens syndrome?

Assuming other non CTD related causes for PAH have been excluded

1 Answer available

How do you clinically distinguish between group I and group III PH in patients with CTD-ILD?

1 Answer available

Based on findings of the INCREASE trial, are you routinely prescribing inhaled treprostinil to patients with group 3 pulmonary hypertension secondary to interstitial lung disease?

1 Answer available

What criteria do you use on echocardiogram and PFT to determine who needs further evaluation for CTD-associated pulmonary hypertension?

1 Answer available

Papers discussed in this category

Eur Heart J, 2015 Aug 29

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Eur Respir J, 2019 Jan 24

Diagnosis of pulmonary hypertension.

N Engl J Med, 2021 Jan 13

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.

Lancet Respir Med, 2021 Jun 29

Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.

Eur Respir J, 2013 Oct 31

Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects.

Am J Respir Crit Care Med,

Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings.

The European respiratory journal, 2019-01

Risk stratification and medical therapy of pulmonary arterial hypertension.

Eur Respir J, 2019 Jan 24

Pulmonary hypertension in chronic lung disease and hypoxia.

Chest, 2021 Feb

Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's.

Circulation, 2001-01-02

Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension.

The European respiratory journal, 2019-05

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Interv Cardiol Clin,

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.

Circ Cardiovasc Qual Outcomes,

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry.

Eur Respir J, 2017 Jun 08

Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.

Ann Am Thorac Soc,

Pulmonary Endarterectomy. Patient Selection, Technical Challenges, and Outcomes.

Blood pressure monitoring, 2022 Oct 20

Nailfold video-capillaroscopy in the study of cardiovascular disease: a systematic review.

International journal of cardiology, 2025 Mar 08

Pulmonary hypertension in patients with Sjögren's syndrome: Gender differences in cardiovascular risk factors and instrumental data.

Related Topics